Lv2
132 积分 2024-12-03 加入
Daraxonrasib for Previously Treated RAS -Mutant Non–Small-Cell Lung Cancer
5天前
已完结
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer
24天前
已完结
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRASG12D-mutant pancreatic cancer: a phase 1b/2 trial
1个月前
已完结
Cancer burden and control in China: landscape, trends and challenges
2个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
3个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
3个月前
已完结
Site-specific mutagenesis screening in KRAS mutant library to uncover resistance mechanisms to KRASG12D inhibitors
3个月前
已完结
Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer
4个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer
4个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
4个月前
已完结
皖公网安备34019202002308
